• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oasmia Pharmaceutical AB

+ Add to Watchlist

OASM:SS

21.6000 SEK 0.1000 0.47%

As of 11:29:59 ET on 08/29/2014.

Company Profile for Oasmia Pharmaceutical AB (OASM)

Oasmia Pharmaceutical AB is a pharmaceutical company that specializes in human and veterinary oncology. The Company's develops the semi-synthesized substances for different therapeutic areas, primarily for anti-cancer chemotherapy. Oasmia also conducts research within antibiotics, asthma and neurologically targeted drugs in clinical or preclinical stages.

Contact Information

Oasmia Pharmaceutical AB

Vallongatan 1
Uppsala, 752 28
Sweden
Phone: 46-1850-5440
Fax: 46-1851-0873

Key Executives for Oasmia Pharmaceutical AB (OASM)

Joel Tomas CitronChairmanJulian AleksovCEO/Co-Founder
Hans SundinExecutive Vice PresidentMargareta ErikssonVP:Clinical Development
Ingela HagglundVP:OperationsAnnette LjungmarkHead:Accounting & Human Resources
Mikael AspHead:Quality Assurance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil